Page 97 - Read Online

Page 14 of 18 Kouroumalis et al. Hepatoma Res 2018;4:34 I http://dx.doi.org/10.20517/2394-5079.2018.33

BMC Cancer 2017;17:896.
18. Notas G, Kolios G, Mastrodimou N, Kampa M, Vasilaki A, Xidakis C, Castanas E, Thermos K, Kouroumalis E. Cortistatin production
by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors. J Hepatol 2004;40:792-8.
19. Samonakis DN, Notas G, Christodoulakis N, Kouroumalis EA. Mechanisms of action and resistance of somatostatin analogues for the
treatment of hepatocellular carcinoma: a message not well taken. Dig Dis Sci 2008;53:2359-65.
20. Siehler S, Seuwen K, Hoyer D. [125I]Tyr10-cortistatin14 labels all five somatostatin receptors. Naunyn Schmiedebergs Arch Pharmacol
1998;357:483-9.
21. Reubi JC, Waser B, Cescato R, Gloor B, Stettler C, Christ E. Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of
octreotidetreated patients. J Clin Endocrinol Metab 2010;95:2343-50.
22. Reynaert H, Vaeyens F, Qin H, Hellemans K, Chatterjee N, Winand D, Quartier E, Schuit F, Urbain D, Kumar U, Patel YC, Geerts A.
Somatostatin suppresses endothelin-1 induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology
2001;121:915-30.
23. Song SH, Leng XH, Li T, Qin ZZ, Peng JR, Zhao L, Wei YH, Yu X. Expression of subtypes of somatostatin receptors in hepatic stellate
cells. World J Gastroenterol 2004;10:1663-5.
24. Klironomos S, Notas G, Sfakianaki O, Kiagiadaki F, Xidakis C, Kouroumalis E. Octreotide modulates the effects on fibrosis of TNF-α,
TGF-β and PDGF in activated rat hepatic stellate cells. Regul Pept 2014;188:5-12.
25. Notas G, Xidakis C, Valatas V, Vasilaki A, Mastrodimou N, Manousou P, Kolios G, Thermos K, Kouroumalis E. LPS modifies the
expression and accumulation of somatostatin receptors in rat Kupffer cells. J Hepatol 2005;42:232.
26. Xidakis C, Mastrodimou N, Notas N, Renieri E, Kolios G, Kouroumalis E, Thermos K. RT-PCR and immunocytochemistry studies
support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cells Reg Pept 2007;143:76-82.
27. Reubi JC, Zimmermann A, Jonas S, Waser B, Neuhaus P, Läderach U, Wiedenmann B. Regulatory peptide receptors in human
hepatocellular carcinomas. Gut 1999;45:766-74.
28. Blaker M, Schmitz M, Gocht A, Burghardt S, Schulz M, Broring DC, Pace A, Greten H, de Weerth A. Differential expression of
somatostatin receptor subtypes in hepatocellular carcinomas. J Hepatol 2004;41:112-8.
29. Xie YM, Yan LN, Wei B, Guo MM, Tang CW. Correlation of somatostatin receptor expression in human hepatocellular carcinoma
tissue to serum alpha-fetoprotein concentration. Ai Zheng 2007;26:688-92. (in Chinese)
30. Verhoef C, van Dekken H, Hofland LJ, Zondervan PE, de Wilt JH, van Marion R, de Man RA, IJzermans JN, van Eijck CH.
Somatostatin receptor in human hepatocellular carcinomas: biological, patient and tumor characteristics. Dig Surg 2008;25:21-6.
31. Koc EU, Ozgur T, Yerci O, Gurel S. Somatostatin receptor 1 (SSTR1) and somatostatin receptor 5 (SSTR5) expression in hepatocellular
carcinoma. Hepatogastroenterology 2013;60:1693-7.
32. Chou CK, Ho LT, Ting LP, Hu CP, Su TS, Chang WC, Suen CS, Huang MY, Chang CM. Selective suppression of insulin-induced
proliferation of cultured human hepatoma cells by somatostatin. J Clin Invest 1987;79:175-8.
33. Chen X, Liu Z, Ai Z. Antineoplastic mechanism of octreotide action in human hepatoma. Chin Med J 2001;114:1167-70.
34. Liu HL, Huo L,Wang L. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells. Acta Pharmacol Sin
2004;25:1380-6.
35. Hua YP, Yin XY, Peng BG, Li SQ, Lai JM, Liang HZ, Liang LJ. Mechanisms and influence of octreotide-induced regulation of
somatostatin receptor 2 on hepatocellular carcinoma. Chemotherapy 2009;55:312-20.
36. Lü XH, Wang CH, Xie Y. Differences of therapeutic efficacy between different kinds of somatostatin analogue for primary
hepatocellular carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban 2017;48:549-55. (in Chinese)
37. Xie Y, Tang CW, Wang CH. Effect of HBV X gene transfection on octreotide-inhibited growth of hepatocellular carcinoma cell line
HepG2. Ai Zheng 2005;24:965-9. (in Chinese)
38. Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, Rosenbaum J. Human hepatic myofibroblasts increase
invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology 1997;26:1458-66.
39. Theret K, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, Campion JP, Boudjéma K, Clément B. Increased extracellular matrix
remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 2001;34:82-8.
40. Pan Q, Li DG, Lu HM, Lu LY, Wang YQ, Xu QF. Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate
cells. World J Gastroenterol 2004;10:1015-8.
41. Reynaert H, Rombouts K, Jia Y, Urbain D, Chatterjee N, Uyama N, Geerts A. Somatostatin at nanomolar concentration reduces collagen
I and III synthesis by, but not proliferation of activated rat hepatic stellate cells. Br J Pharmacol 2005;146:77-88.
42. Wang C, Tang C, Tang L. Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo. Zhonghua Yi
Xue Za Zhi 2001;81:1194-7. (in Chinese)
43. Ferjoux G, Bousquet C, Cordelier P, Benali N, Lopez F, Rochaix P, Buscail L, Susini C. Signal transduction of somatostatin receptors
negatively controlling cell proliferation. J Physiol Paris 2000;94:205-10.
44. Florio T, Yao H, Carey KD, Dillon TJ, Stork PJ. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1
(SSTR1). Mol Endocrinol 1999;13:24-37.
45. Cordelier P, Esteve JP, Bousquet C, Delesque N, Am OC, Schally AV, Vaysse N, Susini C, Buscail L. Characterization of the
antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci U S A 1997;94:9343-8.
46. Lahlou H, Saint-Laurent N, Esteve JP, Eychene A, Pradayrol L, Pyronnet S, Susini C. sst2 Somatostatin receptor inhibits cell
proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation. J Biol Chem 2003;278:39356-71.
47. Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol1997;9:193-204.